title: Thalidomide in patients with multiple myeloma and renal failure.
authors.forename: Fadi
authors.initials: F
authors.lastname: Fakhouri
authors.forename: Houda
authors.initials: H
authors.lastname: Guerraoui
authors.forename: Claire
authors.initials: C
authors.lastname: Presne
authors.forename: Julie
authors.initials: J
authors.lastname: Peltier
authors.forename: Richard
authors.initials: R
authors.lastname: Delarue
authors.forename: Patrice
authors.initials: P
authors.lastname: Muret
authors.forename: Bertrand
authors.initials: B
authors.lastname: Knebelmann
mesh_terms: D000368:Aged; D020533:Angiogenesis Inhibitors / Q000097:blood*; D005260:Female; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced; D007676:Kidney Failure, Chronic / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood*; D013792:Thalidomide / Q000097:blood*
chemical_list: D020533:Angiogenesis Inhibitors; D013792:Thalidomide